-
EP2413923
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2413923
| EP2413923 - DIETARY SUPPLEMENT COMPRISING ALPHA KETO ACIDS FOR SUPPORTING DIABETES THERAPY [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 28.11.2014 Database last updated on 02.11.2024 | Most recent event Tooltip | 28.11.2014 | Application deemed to be withdrawn | published on 31.12.2014 [2015/01] | Applicant(s) | For all designated states Evonik Degussa GmbH Rellinghauser Straße 1-11 45128 Essen / DE | [N/P] |
| Former [2012/06] | For all designated states Evonik Degussa GmbH Rellinghauser Straße 1- 11 45128 Essen / DE | Inventor(s) | 01 /
KARAU, Andreas 13 Rue des Etangs F-60350 Vieux Moulin / FR | 02 /
GEBHARDT, Henrike Wichernstraße 31 48147 Münster / DE | 03 /
WINDHAB, Norbert Ubierstr. 20 65719 Hofheim / DE | 04 /
KOTTENHAHN, Matthias Brückenstr. 9 63579 Freigericht Somborn / DE | 05 /
LIU, Yuefei Im Oberfeld 21/2 89231 Neu-Ulm / DE | 06 /
STEINACKER, Jürgen, M. Johann-Stockar-Weg 22 89075 Ulm / DE | [2012/06] | Representative(s) | (deleted) | [2012/06] | Application number, filing date | 10710309.5 | 22.03.2010 | WO2010EP53704 | Priority number, date | DE20091016119 | 03.04.2009 Original published format: DE102009016119 | [2012/06] | Filing language | DE | Procedural language | DE | Publication | Type: | A1 Application with search report | No.: | WO2010112362 | Date: | 07.10.2010 | Language: | DE | [2010/40] | Type: | A1 Application with search report | No.: | EP2413923 | Date: | 08.02.2012 | Language: | DE | The application published by WIPO in one of the EPO official languages on 07.10.2010 takes the place of the publication of the European patent application. | [2012/06] | Search report(s) | International search report - published on: | EP | 07.10.2010 | Classification | IPC: | A61K31/19, A61K31/194, A23L1/30 | [2012/06] | CPC: |
A61K31/194 (EP,KR,US);
A61K9/08 (KR);
A23D9/00 (EP,KR,US);
A23L33/10 (EP,KR,US);
A61K31/19 (EP,KR,US);
A61P3/10 (EP);
| C-Set: |
A23V2002/00, A23V2200/316, A23V2200/31, A23V2250/02, A23V2200/328 (EP,US)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2012/06] | Title | German: | NAHRUNGSERGÄNZUNGSMITTEL ENTHALTEND ALPHA-KETOSÄUREN ZUR UNTERSTÜTZUNG DER DIABETESTHERAPIE | [2012/06] | English: | DIETARY SUPPLEMENT COMPRISING ALPHA KETO ACIDS FOR SUPPORTING DIABETES THERAPY | [2012/06] | French: | COMPLÉMENTS ALIMENTAIRES CONTENANT DES ALPHA-CÉTO-ACIDES, POUR ÉTAYER LE TRAITEMENT DU DIABÈTE | [2012/06] | Entry into regional phase | 23.09.2011 | National basic fee paid | 23.09.2011 | Designation fee(s) paid | 23.09.2011 | Examination fee paid | Examination procedure | 23.09.2011 | Examination requested [2012/06] | 02.05.2012 | Amendment by applicant (claims and/or description) | 20.01.2014 | Despatch of a communication from the examining division (Time limit: M04) | 31.05.2014 | Application deemed to be withdrawn, date of legal effect [2015/01] | 02.07.2014 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2015/01] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 20.01.2014 | Fees paid | Renewal fee | 23.03.2012 | Renewal fee patent year 03 | 26.03.2013 | Renewal fee patent year 04 | Penalty fee | Additional fee for renewal fee | 31.03.2014 | 05 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XI]DE2712777 (UNIV JOHNS HOPKINS) [X] 1-13,15-18 * page 38, paragraph 2 - page 39, paragraph 1; claim 9 * [I] 14; | [XI]US5817364 (OLIN THOMAS [SE]) [X] 1-13,15-18 * column 5, line 22 - column 8, line 25; claims 1,5,7 * [I] 14; | [A]WO2007002365 (EINSTEIN COLL MED [US], et al) [A] 1-18* page 15, line 29 - page 16, line 2; claims 15,37-39 *; | [XI]US2008058254 (HEUER MARVIN A [CA], et al) [X] 1-13,15-18 * paragraphs [0001] - [0002] - [0038] - [0042]; example 1; claim 9 * [I] 14; | [X]WO2008122613 (EVONIK DEGUSSA GMBH [DE], et al) [X] 1-13,15-18 * page 4, paragraph 2 - page 5, paragraph 2 * * page 6, paragraph 3 - page 7, line 2 * * page 10, paragraph 3 - page 12, line 11 * * page 13, paragraph 1; example 1; claims 2-5,7,8,10--16,18 * | by applicant | US4677121 | US6100287 | - BRUNETTI, A.; I. D. GOLDFINE, "Role of myogenin in myoblast differentiation and its regulation by fibroblast growth factor", J.BIOL.CHEM., (1990), vol. 265, no. 11, pages 5960 - 63 | - FERNANDEZ, A. M. ET AL., "Muscle-specific inactivation of the IGF-I receptor induces compensatory hyperplasia in skeletal muscle", J.CLIN.INVEST, (2002), vol. 109, no. 3, pages 347 - 55 | - RAGOLIA, L.; Q. ZUO; N. BEGUM, "Inhibition of myogenesis by depletion of the glycogenassociated regulatory subunit of protein phosphatase-1 in rat skeletal muscle cells", J.BIOL.CHEM., (2000), vol. 275, no. 34, pages 26102 - 08 | - SUN, Z. ET AL., "Muscular response and adaptation to diabetes mellitus", FRONT BIOSCI., (2008), vol. 13, pages 4765 - 94 | - PHARMA POLYMERE, (200211), pages 1 - 4 | - WALLACE TM; LEVY JC; MATTHEW DR, "Use and Abuse of HOMA Modeling", DIABETES CARE, (2004), vol. 27, pages 1487 - 1495 |